NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling
I'm actually looking to buy in. Not because of the pump but thinking it's oversold. Just waiting for the right moment to ride the wave up. That gap up does look tempting. Question is, at what price i'll put my money in. AHQ